Evidence map›Paper›PMID 33092573›Full record

ArticleBMC palliative care2020

The efficacy of specialised rehabilitation using the Op-reha Guide for cancer patients in palliative care units: protocol of a multicentre, randomised controlled trial (JORTC-RHB02).

Nanako Nishiyama, Yoshinobu Matsuda, Noriko Fujiwara, Keisuke Ariyoshi, Shunsuke Oyamada, Keiichi Narita, Ryouhei Ishii, Satoru Iwase

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC palliative care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Nanako NishiyamaGraduate School of Comprehensive Rehabilitation, Osaka Prefecture University, 3-7-30, Habikino, Habikino-city, Osaka, 583-8555, Japan. rapeblossoms-chi75@outlook.jp.ORCID http://orcid.org/0000-0002-7580-4009
Yoshinobu MatsudaDepartment of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Centre, Sakai, Japan.
Noriko FujiwaraIMSUT Hospital of the Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Keisuke AriyoshiJORTC Data Centre, NPO, Tokyo, Japan.
Shunsuke OyamadaJORTC Data Centre, NPO, Tokyo, Japan.
Keiichi NaritaGraduate School of Medicine, Kyoto University, Kyoto, Japan.
Ryouhei IshiiGraduate School of Comprehensive Rehabilitation, Osaka Prefecture University, 3-7-30, Habikino, Habikino-city, Osaka, 583-8555, Japan.
Satoru IwaseDepartment of Emergency & Palliative Medicine, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Osaka Prefecture University · JPKyoto University · JPNHO Kinki Chuo Chest Medical Center · JPSaitama Medical University · JPUniversity of Tokyo Hospital · JP

Funding

Japan Agency for Medical Research and Development JP18lk0310054, 19lk0310060h001, 20lk031006h002
6 · The paper itself

Abstract

backgroundAlthough rehabilitation is recommended for terminal cancer patients, the specific components and methods of such programs are poorly documented. No studies to date have examined the effectiveness of rehabilitation for terminal cancer patients. This study aims to evaluate the efficacy of a new intervention for rehabilitation therapists, using the Op-reha Guide (Guide to Optimal and Patient-Centred Rehabilitation Practice for Patients in Palliative Care Units [PCUs]) in rehabilitation practice. This guide consists of recommended actions and attitudes for rehabilitation therapists and aims to optimise therapists' actions according to the patient's needs and condition. It shares goals with terminal cancer patients to maintain their activities of daily living (ADL).

methodsThis study uses a multicentre, prospective, randomised controlled trial (RCT) design with two parallel groups in PCUs where specialised rehabilitation will be routinely performed for terminal cancer patients by rehabilitation therapists. Participants will be randomised (1:1) to intervention (the Op-reha Guide) and control groups (usual rehabilitation). We will then conduct an observational study in PCUs that do not perform specialised rehabilitation for terminal cancer patients; this will be considered the usual care group, and the efficacy of usual rehabilitation will be quantitatively evaluated. Inclusion criteria are hospitalisation in PCU, European Cooperative Oncology Group Performance Status of 2 or 3, and clinical estimation of life expectancy of 3 weeks or more. Patients with severe symptom burden will be excluded. We hypothesise that the Op-reha Guide will be more effective in maintaining the ADL of terminal cancer patients hospitalised in PCUs than usual rehabilitation. The primary endpoint is defined as the change in (total) modified Barthel Index from baseline to Day 22. Quality of life will be a secondary endpoint. In total, 135 patients will be recruited from 16 Japanese sites between July 2019 and December 2021. DISCUSSION: This will be the first trial to evaluate the efficacy of specialised rehabilitation for terminal cancer patients hospitalised in PCUs, and will contribute to the evidence on the efficacy of implementing rehabilitation for terminal cancer patients.

trial registrationUMIN-CTR, UMIN000037298 R000042525 (date of registration 7 July 2019).

Indexed as

NeoplasmsPalliative CarePrecision MedicineRehabilitationHumansMulticenter Studies as TopicProspective StudiesRandomized Controlled Trials as TopicActivities of daily livingEnd of lifePalliative care unitQuality of lifeRandomised controlled trialSpecialised rehabilitationTerminal cancer patient

Identifiers

PMID33092573
PMCPMC7579867
OpenAlexW3094336448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.